Serum levels of interleukin-1 receptor antagonist (IL-1ra) in thyroid cancer patients

Langenbeck's Archives of Surgery

Volumn 393, Issue 3, 2008, Pages 275-280

  Niedźwiecki, Sebastian ^a,b   Stępień, Tomasz ^a   Kuzdak, Krzysztof ^a   Stȩpień, Henryk ^a   Krupiński, Roman ^a   Seehofer, Daniel ^b   Rayes, Nada ^b   Ulrich, Frank ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Interleukin 1 receptor antagonist; Thyroid cancer

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; BLOOD CHEMISTRY; CANCER PATIENT; CANCER STAGING; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLICULAR CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDULLARY CARCINOMA; PAPILLARY CARCINOMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; THYROID ADENOMA; THYROID CANCER; VOLUNTEER;

EID: 43349108714     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-007-0251-9     Document Type: Article

References (41)

1. 1. WP Arend M Malyak CJ Guthridge C Gabay 1998 Interleukin-1 receptor antagonist: role in biology Annu Rev Immunol 16 27 55 9597123 10.1146/annurev.immunol.16.1.27 1:CAS:528:DyaK1cXislyitr4%3D Arend WP, Malyak M, Guthridge CJ, Gabay C (1998) Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 16:27–55
2. 2. CA Dinarello 1991 Interleukin-1 and interleukin-1 antagonism Blood 77 1627 1652 1826616 1:CAS:528:DyaK3MXktVKmsLY%3D Dinarello CA (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77:1627–1652
3. 3. CA Dinarello 1994 The biological properties of interleukin-1 Eur Cytokine Netw 5 517 531 7727685 1:CAS:528:DyaK2MXltFCjs70%3D Dinarello CA (1994) The biological properties of interleukin-1. Eur Cytokine Netw 5:517–531
4. 4. LC Platanias NJ Vogelzang 1990 Interleukin-1: biology, pathophysiology, and clinical prospects Am J Med 89 621 629 2239982 10.1016/0002-9343(90)90181-C 1:STN:280:DyaK3M%2FltFGqsQ%3D%3D Platanias LC, Vogelzang NJ (1990) Interleukin-1: biology, pathophysiology, and clinical prospects. Am J Med 89:621–629
5. 5. WP Arend 1990 Interleukin-1 receptor antagonist: discovery, structure and properties Prog Growth Factor Res 2 193 205 2151936 10.1016/0955-2235(90)90018-F 1:CAS:528:DyaK38XjvFajtA%3D%3D Arend WP (1990) Interleukin-1 receptor antagonist: discovery, structure and properties. Prog Growth Factor Res 2:193–205
6. 6. M Muzio F Re M Sironi N Polentarutti A Minty D Caput P Ferrara A Mantovani F Colotta 1994 Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells Blood 83 1738 1743 7908231 1:CAS:528:DyaK2cXisVahsr0%3D Muzio M, Re F, Sironi M, Polentarutti N, Minty A, Caput D, Ferrara P, Mantovani A, Colotta F (1994) Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells. Blood 83:1738–1743
7. 7. RW Janson KR Hance WP Arend 1991 Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor J Immunol 147 4218 4223 1836481 1:STN:280:DyaK38%2FptFOhuw%3D%3D Janson RW, Hance KR, Arend WP (1991) Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor. J Immunol 147:4218–4223
8. 8. RF Krzesicki CA Hatfield MJ Bienkowski JC McGuire GE Winterrowd DL Chapman AE Berger RN McEwan DB Carter JG Chosay 1993 Regulation of expression of IL-1 receptor antagonist protein in human synovial and dermal fibroblasts J Immunol 150 4008 4018 8473746 1:CAS:528:DyaK3sXkt1KnsL8%3D Krzesicki RF, Hatfield CA, Bienkowski MJ, McGuire JC, Winterrowd GE, Chapman DL, Berger AE, McEwan RN, Carter DB, Chosay JG et al (1993) Regulation of expression of IL-1 receptor antagonist protein in human synovial and dermal fibroblasts. J Immunol 150:4008–4018
9. 9. DJ Dripps BJ Brandhuber RC Thompson SP Eisenberg 1991 Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction J Biol Chem 266 10331 10336 1828071 1:CAS:528:DyaK3MXkt1Ont70%3D Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP (1991) Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 266:10331–10336
10. 10. E Hirsch VM Irikura SM Paul D Hirsh 1996 Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice Proc Natl Acad Sci U S A 93 11008 11013 8855299 10.1073/pnas.93.20.11008 1:CAS:528:DyaK28XmtVOkt78%3D Hirsch E, Irikura VM, Paul SM, Hirsh D (1996) Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci U S A 93:11008–11013
11. 11. C Gabay MF Smith D Eidlen WP Arend 1997 Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein J Clin Invest 99 2930 2940 9185517 10.1172/JCI119488 1:CAS:528:DyaK2sXktV2qur8%3D Gabay C, Smith MF, Eidlen D, Arend WP (1997) Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J Clin Invest 99:2930–2940
12. 12. AM Prieur MT Kaufmann C Griscelli JM Dayer 1987 Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis Lancet 2 1240 1242 2890857 10.1016/S0140-6736(87)91854-X 1:STN:280:DyaL1c%2FmsVKntw%3D%3D Prieur AM, Kaufmann MT, Griscelli C, Dayer JM (1987) Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis. Lancet 2:1240–1242
13. 13. C Gabay F Gay-Croisier P Roux-Lombard O Meyer C Maineti PA Guerne T Vischer JM Dayer 1994 Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response Arthritis Rheum 37 1744 1751 7986220 10.1002/art.1780371206 1:STN:280:DyaK2M%2FnslGmug%3D%3D Gabay C, Gay-Croisier F, Roux-Lombard P, Meyer O, Maineti C, Guerne PA, Vischer T, Dayer JM (1994) Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response. Arthritis Rheum 37:1744–1751
14. 14. H Suzuki H Takemura H Kashiwagi 1995 Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus. Enhanced production by monocytes and correlation with disease activity Arthritis Rheum 38 1055 1059 7639800 10.1002/art.1780380806 1:CAS:528:DyaK2MXns1WisL4%3D Suzuki H, Takemura H, Kashiwagi H (1995) Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus. Enhanced production by monocytes and correlation with disease activity. Arthritis Rheum 38:1055–1059
15. 15. MA Rogy SM Coyle HS Oldenburg CS Rock PS Barie KJ Zee Van CG Smith LL Moldawer SF Lowry 1994 Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients J Am Coll Surg 178 132 138 8173722 1:STN:280:DyaK2c3ivVShsw%3D%3D Rogy MA, Coyle SM, Oldenburg HS, Rock CS, Barie PS, Van Zee KJ, Smith CG, Moldawer LL, Lowry SF (1994) Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. J Am Coll Surg 178:132–138
16. 16. JH Pruitt MB Welborn PD Edwards TR Harward JW Seeger TD Martin C Smith JA Kenney RI Wesdorp S Meijer MA Cuesta A Abouhanze EM Copeland 3rd J Giri JE Sims LL Moldawer HS Oldenburg 1996 Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome Blood 87 3282 3288 8605344 1:CAS:528:DyaK28Xit1Krs78%3D Pruitt JH, Welborn MB, Edwards PD, Harward TR, Seeger JW, Martin TD, Smith C, Kenney JA, Wesdorp RI, Meijer S, Cuesta MA, Abouhanze A, Copeland EM 3rd, Giri J, Sims JE, Moldawer LL, Oldenburg HS (1996) Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 87:3282–3288
17. 17. SW Chensue KS Warmington AE Berger DE Tracey 1992 Immunohistochemical demonstration of interleukin-1 receptor antagonist protein and interleukin-1 in human lymphoid tissue and granulomas Am J Pathol 140 269 275 1531398 1:STN:280:DyaK387lt1ejtQ%3D%3D Chensue SW, Warmington KS, Berger AE, Tracey DE (1992) Immunohistochemical demonstration of interleukin-1 receptor antagonist protein and interleukin-1 in human lymphoid tissue and granulomas. Am J Pathol 140:269–275
18. 18. F Lindmark SL Zheng F Wiklund KA Balter J Sun B Chang M Hedelin J Clark JE Johansson DA Meyers HO Adami W Isaacs H Gronberg J Xu 2005 Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk Br J Cancer 93 493 497 16106254 10.1038/sj.bjc.6602729 1:CAS:528:DC%2BD2MXnvFymu7g%3D Lindmark F, Zheng SL, Wiklund F, Balter KA, Sun J, Chang B, Hedelin M, Clark J, Johansson JE, Meyers DA, Adami HO, Isaacs W, Gronberg H, Xu J (2005) Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk. Br J Cancer 93:493–497
19. 19. F Graziano A Ruzzo D Santini B Humar G Tonini V Catalano R Berardi F Pizzagalli F Arduini I Bearzi M Scartozzi S Cascinu E Testa R Ficarelli M Magnani 2005 Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer J Clin Oncol 23 2339 2345 15800325 10.1200/JCO.2005.02.345 1:CAS:528:DC%2BD2MXjsVyhsro%3D Graziano F, Ruzzo A, Santini D, Humar B, Tonini G, Catalano V, Berardi R, Pizzagalli F, Arduini F, Bearzi I, Scartozzi M, Cascinu S, Testa E, Ficarelli R, Magnani M (2005) Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer. J Clin Oncol 23:2339–2345
20. 20. MS Al-Moundhri M Al-Nabhani B Al-Bahrani IA Burney A Al-Madhani SS Ganguly SA Al-Yahyaee CS Grant 2006 Interleukin-1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms and gastric cancer risk in an Omani Arab population Gastric Cancer 9 284 290 17235630 10.1007/s10120-006-0392-5 1:CAS:528:DC%2BD28Xht1emsr%2FE Al-Moundhri MS, Al-Nabhani M, Al-Bahrani B, Burney IA, Al-Madhani A, Ganguly SS, Al-Yahyaee SA, Grant CS (2006) Interleukin-1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms and gastric cancer risk in an Omani Arab population. Gastric Cancer 9:284–290
21. 21. J Sehouli A Mustea D Koensgen FC Chen W Lichtenegger 2003 Interleukin-1 receptor antagonist gene polymorphism is associated with increased risk of epithelial ovarian cancer Ann Oncol 14 1501 1504 14504049 10.1093/annonc/mdg413 1:STN:280:DC%2BD3svktlKjtA%3D%3D Sehouli J, Mustea A, Koensgen D, Chen FC, Lichtenegger W (2003) Interleukin-1 receptor antagonist gene polymorphism is associated with increased risk of epithelial ovarian cancer. Ann Oncol 14:1501–1504
22. 22. S Santtila K Savinainen M Hurme 1998 Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro Scand J Immunol 47 195 198 9519856 10.1046/j.1365-3083.1998.00300.x 1:CAS:528:DyaK1cXitlChurw%3D Santtila S, Savinainen K, Hurme M (1998) Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 47:195–198
23. 23. VA Danis M Millington VJ Hyland D Grennan 1995 Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism Clin Exp Immunol 99 303 310 7851026 1:CAS:528:DyaK2MXktl2hs70%3D 10.1111/j.1365-2249.1995.tb05549.x Danis VA, Millington M, Hyland VJ, Grennan D (1995) Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 99:303–310
24. 24. HJ Gruss G Dolken MA Brach R Mertelsmann F Herrmann 1992 High concentrations of the interleukin-1 receptor antagonist in serum of patients with Hodgkin's disease Lancet 340 968 1357359 10.1016/0140-6736(92)92849-B 1:STN:280:DyaK3s%2Fitlarsg%3D%3D Gruss HJ, Dolken G, Brach MA, Mertelsmann R, Herrmann F (1992) High concentrations of the interleukin-1 receptor antagonist in serum of patients with Hodgkin's disease. Lancet 340:968
25. 25. DR Smith SL Kunkel TJ Standiford SW Chensue MW Rolfe MB Orringer RI Whyte MD Burdick JM Danforth AR Gilbert 1993 The production of interleukin-1 receptor antagonist by human bronchogenic carcinoma Am J Pathol 143 794 803 8362978 1:STN:280:DyaK3szntVGmug%3D%3D Smith DR, Kunkel SL, Standiford TJ, Chensue SW, Rolfe MW, Orringer MB, Whyte RI, Burdick MD, Danforth JM, Gilbert AR et al (1993) The production of interleukin-1 receptor antagonist by human bronchogenic carcinoma. Am J Pathol 143:794–803
26. 26. R Fujiwaki T Hata K Miyazaki T Kawamura K Inada 1997 Elevation of serum interleukin-1 receptor antagonist levels in women with gynaecological cancers Br J Obstet Gynaecol 104 1407 1408 9422021 1:CAS:528:DyaK1cXjtVagtw%3D%3D Fujiwaki R, Hata T, Miyazaki K, Kawamura T, Inada K (1997) Elevation of serum interleukin-1 receptor antagonist levels in women with gynaecological cancers. Br J Obstet Gynaecol 104:1407–1408
27. 27. E Oelmann A Kraemer H Serve B Reufi D Oberberg S Patt H Herbst H Stein E Thiel WE Berdel 1997 Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1 Int J Cancer 71 1066 1076 9185713 10.1002/(SICI)1097-0215(19970611)71:6<1066::AID-IJC25>3.0.CO;2-A 1:CAS:528:DyaK2sXktVyrsb8%3D Oelmann E, Kraemer A, Serve H, Reufi B, Oberberg D, Patt S, Herbst H, Stein H, Thiel E, Berdel WE (1997) Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1. Int J Cancer 71:1066–1076
28. 28. L Le Van S Haskill GJ Jaffe WC Fowler Jr 1991 Expression of interleukin-1 and interleukin-1 receptor antagonists in endometrial cancer Gynecol Oncol 42 161 164 1832651 10.1016/0090-8258(91)90338-6 Van Le L, Haskill S, Jaffe GJ, Fowler WC Jr (1991) Expression of interleukin-1 and interleukin-1 receptor antagonists in endometrial cancer. Gynecol Oncol 42:161–164
29. 29. N Iizuka S Hazama K Hirose T Abe N Tokuda T Fukumoto A Tangoku M Oka 1999 Interleukin-1 receptor antagonist mRNA expression and the progression of gastric carcinoma Cancer Lett 142 179 184 10463774 10.1016/S0304-3835(99)00162-7 1:CAS:528:DyaK1MXksV2ktbk%3D Iizuka N, Hazama S, Hirose K, Abe T, Tokuda N, Fukumoto T, Tangoku A, Oka M (1999) Interleukin-1 receptor antagonist mRNA expression and the progression of gastric carcinoma. Cancer Lett 142:179–184
30. 30. LA Hefler E Ludwig A Lebrecht R Zeillinger D Tong-Cacsire H Koelbl S Leodolter CB Tempfer 2002 Polymorphisms of the interleukin-1 gene cluster and ovarian cancer J Soc Gynecol Investig 9 386 390 12445604 10.1016/S1071-5576(02)00177-6 1:CAS:528:DC%2BD38XoslGhtLY%3D Hefler LA, Ludwig E, Lebrecht A, Zeillinger R, Tong-Cacsire D, Koelbl H, Leodolter S, Tempfer CB (2002) Polymorphisms of the interleukin-1 gene cluster and ovarian cancer. J Soc Gynecol Investig 9:386–390
31. 31. KM Lee SK Park N Hamajima K Tajima JY Choi DY Noh SH Ahn KY Yoo A Hirvonen D Kang 2006 Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women Breast Cancer Res Treat 96 197 202 16319982 10.1007/s10549-005-9079-6 1:CAS:528:DC%2BD28XivVent74%3D Lee KM, Park SK, Hamajima N, Tajima K, Choi JY, Noh DY, Ahn SH, Yoo KY, Hirvonen A, Kang D (2006) Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women. Breast Cancer Res Treat 96:197–202
32. 32. RJ Wilkinson P Patel M Llewelyn CS Hirsch G Pasvol G Snounou RN Davidson Z Toossi 1999 Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis J Exp Med 189 1863 174 10377182 10.1084/jem.189.12.1863 1:CAS:528:DyaK1MXktVent7k%3D Wilkinson RJ, Patel P, Llewelyn M, Hirsch CS, Pasvol G, Snounou G, Davidson RN, Toossi Z (1999) Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med 189:1863–174
33. 33. V Speirs MJ Kerin CJ Newton DS Walton AR Green SB Desai SL Atkin 1999 Evidence for transcriptional activation of ERalpha by IL-1beta in breast cancer cells Int J Oncol 15 1251 1254 10568836 1:CAS:528:DC%2BD3cXhsVelsQ%3D%3D Speirs V, Kerin MJ, Newton CJ, Walton DS, Green AR, Desai SB, Atkin SL (1999) Evidence for transcriptional activation of ERalpha by IL-1beta in breast cancer cells. Int J Oncol 15:1251–1254
34. 34. H Ito C Miki 1999 Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients Scand J Gastroenterol 34 1139 1143 10582766 10.1080/003655299750024959 1:CAS:528:DyaK1MXnvVGgu74%3D Ito H, Miki C (1999) Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients. Scand J Gastroenterol 34:1139–1143
35. 35. E Fischer KJ Zee Van MA Marano CS Rock JS Kenney DD Poutsiaka CA Dinarello SF Lowry LL Moldawer 1992 Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease Blood 79 2196 2200 1533321 1:CAS:528:DyaK38XktVGrs7s%3D Fischer E, Van Zee KJ, Marano MA, Rock CS, Kenney JS, Poutsiaka DD, Dinarello CA, Lowry SF, Moldawer LL (1992) Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 79:2196–2200
36. 36. V Dossow Von S Baur M Sander H Tnnesen C Marks C Paschen G Berger CD Spies 2007 Propofol increased the interleukin-6 to interleukin-10 ratio more than isoflurane after surgery in long-term alcoholic patients J Int Med Res 35 395 405 Von Dossow V, Baur S, Sander M, Tnnesen H, Marks C, Paschen C, Berger G, Spies CD (2007) Propofol increased the interleukin-6 to interleukin-10 ratio more than isoflurane after surgery in long-term alcoholic patients. J Int Med Res 35:395–405
37. 37. XH Cai SP Wang XT Chen SL Peng MH Cao XJ Ye YZ Yang 2007 Comparison of three analgesic methods for postoperative pain relief and their effects on plasma interleukin-6 concentration following radical surgery for gastric carcinoma Nan Fang Yi Ke Da Xue Xue Bao 27 387 389 17426001 1:CAS:528:DC%2BD2sXkvVOmt7Y%3D Cai XH, Wang SP, Chen XT, Peng SL, Cao MH, Ye XJ, Yang YZ (2007) Comparison of three analgesic methods for postoperative pain relief and their effects on plasma interleukin-6 concentration following radical surgery for gastric carcinoma. Nan Fang Yi Ke Da Xue Xue Bao 27:387–389
38. 38. TJ Szczesny R Slotwinski A Stankiewicz B Szczygiel M Zaleska M Kopacz 2007 Interleukin 6 and interleukin 1 receptor antagonist as early markers of complications after lung cancer surgery Eur J Cardiothorac Surg 31 719 724 17317198 10.1016/j.ejcts.2007.01.027 Szczesny TJ, Slotwinski R, Stankiewicz A, Szczygiel B, Zaleska M, Kopacz M (2007) Interleukin 6 and interleukin 1 receptor antagonist as early markers of complications after lung cancer surgery. Eur J Cardiothorac Surg 31:719–724
39. 39. SS Witkin S Gerber WJ Ledger 2002 Influence of interleukin-1 receptor antagonist gene polymorphism on disease Clin Infect Dis 34 204 209 11740709 10.1086/338261 1:CAS:528:DC%2BD38XntFOjtA%3D%3D Witkin SS, Gerber S, Ledger WJ (2002) Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 34:204–209
40. 40. L Renzo Di M Bigioni V Del Gobbo MG Premrov U Barbini N Lorenzo Di A Lorenzo De 2007 Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 alpha and beta plasma levels Pharmacol Res 55 131 138 17174563 10.1016/j.phrs.2006.11.002 1:CAS:528:DC%2BD2sXhtlSjtbk%3D Di Renzo L, Bigioni M, Del Gobbo V, Premrov MG, Barbini U, Di Lorenzo N, De Lorenzo A (2007) Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 alpha and beta plasma levels. Pharmacol Res 55:131–138
41. 41. H Ashdown S Poole P Boksa GN Luheshi 2007 Interleukin-1 receptor antagonist as a modulator of gender differences in the febrile response to lipopolysaccharide in rats Am J Physiol Regul Integr Comp Physiol 292 R1667 R1674 17138728 1:CAS:528:DC%2BD2sXks1KitLo%3D Ashdown H, Poole S, Boksa P, Luheshi GN (2007) Interleukin-1 receptor antagonist as a modulator of gender differences in the febrile response to lipopolysaccharide in rats. Am J Physiol Regul Integr Comp Physiol 292:R1667–R1674